Merigold, a producer of imaging trial documentation, has partnered with Log10 to bring automation to medical and regulatory writing.
The collaboration has produced Bloom AI, a purpose-built software that allows medical writers and clinical teams to generate first drafts of regulatory documents.
Powered by Log10's Everest platform, Bloom AI combines Merigold's imaging expertise with Log10's generative AI technology to process thousands of pages of text, images, and data -- resulting in submission-ready documents for imaging trials.
Bloom AI automates document drafting, including for the imaging charter, imaging project plan, and imaging quality monitoring plan. Bloom AI helped the company achieve up to 70% faster study startup, according to Merigold.
The Everest platform supports generative AI workflows that can automate life sciences documents from preclinical through commercialization phases. Documents range from investigational new drug applications to 510(k) submissions to the U.S. Food and Drug Administration, Merigold said.
